These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20274793)

  • 1. The effects of quinacrine (atabrine) suppression on the course of Pacific vivax malaria.
    LONDON IM; LAVIETES PH
    Am J Med; 1946 Dec; 1(6):615-20. PubMed ID: 20274793
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on atabrine (quinacrine) suppression of malaria; the epidemiological significance of atabrine suppression.
    BANG FB; HAIRSTON NG
    Am J Trop Med Hyg; 1947 Jan; 27(1):31-8. PubMed ID: 20284807
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of benign tertian malaria with mepacrine; an investigation of 247 cases of apparent failure.
    BROWN M; RENNIE JL
    Ann Trop Med Parasitol; 1946 Jul; 40():190-8. PubMed ID: 20997903
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative efficiency of quinacrine (atabrine) and quinine in treatment of acute attacks of vivax malaria.
    MOST H; HAYMAN JM
    Am J Med Sci; 1946 Mar; 211():320-4. PubMed ID: 21017159
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma quinacrine concentration in treatment of Plasmodium vivax malaria acquired in the South Pacific.
    ELLERBROOK LD; LIPPINCOTT SW
    Arch Intern Med (Chic); 1945; 76():352-7. PubMed ID: 21011891
    [No Abstract]   [Full Text] [Related]  

  • 6. Atabrine studies in the field; the relation of serum atabrine level to breakthrough of previously contracted vivax malaria.
    SCHAFFER AJ; LEWIS RA
    Bull Johns Hopkins Hosp; 1946 May; 78():265-81. PubMed ID: 20982232
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on atabrine suppression of malaria; an evaluation of atabrine suppression in the field.
    BANG FB; HAIRSTON NG
    Am J Trop Med Hyg; 1946 Nov; 26(6):753-9. PubMed ID: 20279489
    [No Abstract]   [Full Text] [Related]  

  • 8. Vivax relapse rates following continued atabrine suppressive medication; observations on malaria in an infantry regiment.
    BAKER BM; PLATT D
    Bull Johns Hopkins Hosp; 1947 Nov; 81(5):295-304. PubMed ID: 20268502
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of quinine and quinacrine in the treatment of the clinical attacks of vivax malaria.
    GORDON HH; CHRISTIANSON HB; LIPPINCOTT SW
    South Med J; 1946 Aug; 39(8):631-4. PubMed ID: 20993246
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in human malaria; trials of quinacrine, colchicine (SN 12,080) and quinine against Chesson strain vivax malaria.
    COATNEY HR; COOPER WC
    Am J Hyg; 1949 Sep; 50(2):194-9. PubMed ID: 18141119
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of chloroquine, quinacrine (atabrine) and quinine in the treatment of acute attacks of sporozoite-induced vivax malaria, Chesson strain.
    PULLMAN TN; CRAIGE B
    J Clin Invest; 1948 May; 27(3 Pt1):46-50. PubMed ID: 18860178
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute attacks of vivax and falciparum malaria; a comparison of atabrine and quinine.
    BANG FB; HAIRSTON NG
    Bull U S Army Med Dep; 1947 Jan; 7(1):75-89. PubMed ID: 20278999
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on atabrine (quinacrine) suppression of malaria.
    BANG FB; HAIRSTON NG
    Am J Trop Med Hyg; 1946 Sep; 26(5):649-61. PubMed ID: 21003273
    [No Abstract]   [Full Text] [Related]  

  • 14. Quinacrine hydrochloride (atabrine) as a malaria suppressive agent.
    DUNCAN GG
    Air Surg Bull; 1945; 2():413. PubMed ID: 21004527
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation of plasma level of atabrine to morphology and motility of Plasmodium vivax.
    TRAGER W; BANG FB; HAIRSTON NG
    Proc Soc Exp Biol Med; 1945 Nov; 60():257. PubMed ID: 21006309
    [No Abstract]   [Full Text] [Related]  

  • 16. Mepacrine metabolism in recurring benign tertian malaria.
    BROWN M; RENNIE JL
    Ann Trop Med Parasitol; 1946 Dec; 40(3-4):337-46. PubMed ID: 20289235
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on synthetic antimalarial drugs; a comparison of the therapeutic actions of 3349 and of mepacrine hydrochloride on acute attacks of benign tertian malaria.
    ADAMS AR; SANDERSON G
    Ann Trop Med Parasitol; 1945 Dec; 39():180. PubMed ID: 21013248
    [No Abstract]   [Full Text] [Related]  

  • 18. The relation of the plasma concentration of quinacrine to its antimalarial activity.
    MARSHALL EK; DEARBORN EH
    J Pharmacol Exp Ther; 1946 Oct; 88(2):142-53. PubMed ID: 20274536
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood plasma atabrine levels obtained with suppressive and therapeutic doses of atabrine dihydrochloride.
    SMITH PK; GALLUP BN; CAIN LJ
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):360-3. PubMed ID: 20279255
    [No Abstract]   [Full Text] [Related]  

  • 20. PLASMA quinacrine concentration as a function of dosage and environment.
    Arch Intern Med (Chic); 1946 Jul; 78():64-107. PubMed ID: 20994320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.